Effects of protein interaction data integration, representation and reliability on the use of network properties for drug target prediction

BMC Bioinformatics

Volumn 13, Issue 1, 2012, Pages

  Mora, Antonio ^a   Donaldson, Ian M ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DATA RELIABILITY; DRUG TARGETS; INTEGRATION STRATEGY; INTERACTION NETWORKS; INTERACTOME; NETWORK PROPERTIES; PROTEIN INTERACTION; REPRESENTATION TECHNIQUES;

DATA INTEGRATION; ENZYME INHIBITION; INTEGRATION; PROTEINS; RELIABILITY;

DRUG INTERACTIONS;

PROTEIN;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; METABOLISM; PROTEIN PROTEIN INTERACTION;

DRUG DELIVERY SYSTEMS; HUMANS; PROTEIN INTERACTION MAPS; PROTEINS;

MLCS; MLOWN;

EID: 84868647779     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-13-294     Document Type: Article

References (63)

1. Yildirim MA, Goh KI, Cusick ME, Barabasi AL, Vidal M. Drug-target network. Nat Biotechnol 2007, 25(10):1119-1126.
2. Sakharkar MK, Li P, Zhong Z, Sakharkar KR. Quantitative analysis on the characteristics of targets with FDA approved drugs. Int J Biol Sci 2008, 4(1):15-22.
3. Ma'ayan A, Jenkins SL, Goldfarb J, Iyengar R. Network analysis of FDA approved drugs and their targets. Mt Sinai J Med 2007, 74(1):27-32.
4. Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov 2002, 1(9):727-730.
5. Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P. Drug target identification using side-effect similarity. Science 2008, 321(5886):263-266.
6. Li Q, Lai L. Prediction of potential drug targets based on simple sequence properties. BMC Bioinforma 2007, 8:353.
7. Yao L, Rzhetsky A. Quantitative systems-level determinants of human genes targeted by successful drugs. Genome Res 2008, 18(2):206-213.
8. Chen X, Liu MX, Yan GY. Drug-target interaction prediction by random walk on the heterogeneous network. Mol Biosyst 2012, 8(7):1970-1978.
9. Cheng F, Liu C, Jiang J, Lu W, Li W, Liu G, Zhou W, Huang J, Tang Y. Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput Biol 2012, 8(5):e1002503.
10. Yang Y, Adelstein SJ, Kassis AI. Target discovery from data mining approaches. Drug Discov Today 2009, 14(3-4):147-154.
11. Chen B, Ding Y, Wild DJ. Assessing drug target association using semantic linked data. PLoS Comput Biol 2012, 8(7):e1002574.
12. Yamanishi Y, Araki M, Gutteridge A, Honda W, Kanehisa M. Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics 2008, 24(13):i232-240.
13. Zhao S, Li S. Network-based relating pharmacological and genomic spaces for drug target identification. PLoS One 2010, 5(7):e11764.
14. Hwang WC, Zhang A, Ramanathan M. Identification of information flow-modulating drug targets: a novel bridging paradigm for drug discovery. Clin Pharmacol Ther 2008, 84(5):563-572.
15. Chen L, Wang Q, Zhang L, Tai J, Wang H, Li W, Li X, He W. A novel paradigm for potential drug-targets discovery: quantifying relationships of enzymes and cascade interactions of neighboring biological processes to identify drug-targets. Mol Biosyst 2011, 7(4):1033-1041.
16. Zhu M, Gao L, Li X, Liu Z, Xu C, Yan Y, Walker E, Jiang W, Su B, Chen X, et al. The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network. J Drug Target 2009, 17(7):524-532.
17. Korcsmáros T, Szalay MS, Böde C, Kovács IA, Csermely P. How to design multi-target drugs. Expert Opin Drug Discov 2007, 2(6):10.
18. Hase T, Tanaka H, Suzuki Y, Nakagawa S, Kitano H. Structure of protein interaction networks and their implications on drug design. PLoS Comput Biol 2009, 5(10):e1000550.
19. Razick S, Magklaras G, Donaldson IM. iRefIndex: a consolidated protein interaction database with provenance. BMC Bioinforma 2008, 9:405.
20. Bader GD, Donaldson I, Wolting C, Ouellette BF, Pawson T, Hogue CW. BIND-The Biomolecular Interaction Network Database. Nucleic Acids Res 2001, 29(1):242-245.
21. Stark C, Breitkreutz BJ, Chatr-Aryamontri A, Boucher L, Oughtred R, Livstone MS, Nixon J, Van Auken K, Wang X, Shi X, et al. The BioGRID Interaction Database: 2011 update. Nucleic Acids Res 2011, 39(Database issue):D698-D704.
22. Ruepp A, Waegele B, Lechner M, Brauner B, Dunger-Kaltenbach I, Fobo G, Frishman G, Montrone C, Mewes HW. CORUM: the comprehensive resource of mammalian protein complexes--2009. Nucleic Acids Res 2010, 38(Database issue):D497-D501.
23. Xenarios I, Salwinski L, Duan XJ, Higney P, Kim SM, Eisenberg D. DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions. Nucleic Acids Res 2002, 30(1):303-305.
24. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R, Shafreen B, Venugopal A, et al. Human Protein Reference Database--2009 update. Nucleic Acids Res 2009, 37(Database issue):D767-D772.
25. Lynn DJ, Winsor GL, Chan C, Richard N, Laird MR, Barsky A, Gardy JL, Roche FM, Chan TH, Shah N, et al. InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol Syst Biol 2008, 4:218.
26. Kerrien S, Aranda B, Breuza L, Bridge A, Broackes-Carter F, Chen C, Duesbury M, Dumousseau M, Feuermann M, Hinz U, et al. The IntAct molecular interaction database in 2012. Nucleic Acids Res 2012, 40(Database issue):D841-D846.
27. Chautard E, Fatoux-Ardore M, Ballut L, Thierry-Mieg N, Ricard-Blum S. MatrixDB, the extracellular matrix interaction database. Nucleic Acids Res 2011, 39(Database issue):D235-D240.
28. Licata L, Briganti L, Peluso D, Perfetto L, Iannuccelli M, Galeota E, Sacco F, Palma A, Nardozza AP, Santonico E, et al. MINT, the molecular interaction database: 2012 update. Nucleic Acids Res 2012, 40(Database issue):D857-861.
29. Guldener U, Munsterkotter M, Oesterheld M, Pagel P, Ruepp A, Mewes HW, Stumpflen V. MPact: the MIPS protein interaction resource on yeast. Nucleic Acids Res 2006, 34(Database issue):D436-D441.
30. Goll J, Rajagopala SV, Shiau SC, Wu H, Lamb BT, Uetz P. MPIDB: the microbial protein interaction database. Bioinformatics 2008, 24(15):1743-1744.
31. Pagel P, Kovac S, Oesterheld M, Brauner B, Dunger-Kaltenbach I, Frishman G, Montrone C, Mark P, Stumpflen V, Mewes HW, et al. The MIPS mammalian protein-protein interaction database. Bioinformatics 2005, 21(6):832-834.
32. Brown KR, Jurisica I. Online predicted human interaction database. Bioinformatics 2005, 21(9):2076-2082.
33. Mora A, Donaldson IM. iRefR: an R package to manipulate the iRefIndex consolidated protein interaction database. BMC Bioinforma 2011, 12(1):455.
34. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 2005, 437(7062):1173-1178.
35. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005, 122(6):957-968.
36. Deane CM, Salwinski L, Xenarios I, Eisenberg D. Protein interactions: two methods for assessment of the reliability of high throughput observations. Mol Cell Proteomics 2002, 1(5):349-356.
37. MITAB for iRefIndex 8.0 http://irefindex.uio.no/wiki/README_MITAB2.6_for_iRefIndex_8.0.
38. Razick S, Mora A, Michalickova K, Boddie P, Donaldson IM. iRefScape. A Cytoscape plug-in for visualization and data mining of protein interaction data from iRefIndex. BMC Bioinforma 2011, 12:388.
39. von Mering C, Krause R, Snel B, Cornell M, Oliver SG, Fields S, Bork P. Comparative assessment of large-scale data sets of protein-protein interactions. Nature 2002, 417(6887):399-403.
40. Yu H, Braun P, Yildirim MA, Lemmens I, Venkatesan K, Sahalie J, Hirozane-Kishikawa T, Gebreab F, Li N, Simonis N, et al. High-quality binary protein interaction map of the yeast interactome network. Science 2008, 322(5898):104-110.
41. PSISCORE Registry http://psiscore.bioinf.mpi-inf.mpg.de/registry.php.
42. MI scores http://docs.google.com/Doc?docid=0AQ_p-HKWUjHoZGQ5cGNtcmhfMjJ2ZDdwcDhmag&hl=en.
43. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature genetics 2000, 25(1):25-29.
44. Apic G, Ignjatovic T, Boyer S, Russell RB. Illuminating drug discovery with biological pathways. FEBS Lett 2005, 579(8):1872-1877.
45. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28(1):27-30.
46. Green ML, Karp PD. The outcomes of pathway database computations depend on pathway ontology. Nucleic Acids Res 2006, 34(13):3687-3697.
47. Soh D, Dong D, Guo Y, Wong L. Consistency, comprehensiveness, and compatibility of pathway databases. BMC Bioinforma 2010, 11:449.
48. Stobbe MD, Houten SM, Jansen GA, van Kampen AH, Moerland PD. Critical assessment of human metabolic pathway databases: a stepping stone for future integration. BMC Syst Biol 2011, 5:165.
49. Karp PD, Riley M, Paley SM, Pellegrini-Toole A. The MetaCyc Database. Nucleic Acids Res 2002, 30(1):59-61.
50. Caspi R, Altman T, Dale JM, Dreher K, Fulcher CA, Gilham F, Kaipa P, Karthikeyan AS, Kothari A, Krummenacker M, et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res 2010, 38(Database issue):D473-D479.
51. da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4(1):44-57.
52. da Huang W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37(1):1-13.
53. Kamburov A, Wierling C, Lehrach H, Herwig R. ConsensusPathDB--a database for integrating human functional interaction networks. Nucleic Acids Res 2009, 37(Database issue):D623-D628.
54. Schrattenholz A, Groebe K, Soskic V. Systems Biology Approaches and Tools for Analysis of Interactomes and Multi-target Drugs. Systems Biology in Drug Discovery and Development: Methods and Protocols 2010, 29-58. Springer Science, New York, Yan Q, vol. 662.
55. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 2006, 34((Database issue):D668-D672.
56. Gunther S, Kuhn M, Dunkel M, Campillos M, Senger C, Petsalaki E, Ahmed J, Urdiales EG, Gewiess A, Jensen LJ, et al. SuperTarget and Matador: resources for exploring drug-target relationships. Nucleic Acids Res 2008, 36(Database issue):D919-D922.
57. Zhu F, Shi Z, Qin C, Tao L, Liu X, Xu F, Zhang L, Song Y, Zhang J, Han B, et al. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res 2012, 40(Database issue):D1128-1136.
58. McDonagh EM, Whirl-Carrillo M, Garten Y, Altman RB, Klein TE. From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource. Biomark Med 2011, 5(6):795-806.
59. Drug Field Documentation and Sources http://drugbank.ca/documentation.
60. igraph: Network analysis and visualization http://cran.r-project.org/web/packages/igraph/index.html.
61. org.Hs.eg.db -Genome-wide annotation for Human http://www.bioconductor.org/packages/2.2/data/annotation/html/org.Hs.eg.db.html.
62. Hanczar B, Hua J, Sima C, Weinstein J, Bittner M, Dougherty ER. Small-sample precision of ROC-related estimates. Bioinformatics 2010, 26(6):822-830.
63. Hand DJ. Measuring classifier performance: a coherent alternative to the area under the ROC curve. Mach Learn 2009, 77:21.